AlzeCure Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.2%.

Top 19 shareholders own 36.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.91%	Bwg Invest S.à R.L.	8,747,295	€816.1k	0%	no data
4.98%	FV Group AB	4,400,000	€410.5k	0%	no data
4.98%	Sjuenda Holding AB	4,400,000	€410.5k	0%	no data
2.76%	Avanza Fonder AB	2,436,510	€227.3k	0%	no data
2.59%	Skandinaviska Enskilda Banken AB, Private Banking, Investment Banking, and Insurance Arm	2,286,666	€213.3k	0%	no data
2.1%	Futur Pension Försäkringsaktiebolag, Asset Management Arm	1,856,230	€173.2k	0%	0.06%
2.09%	Nordnet AB (publ), Asset Management Arm	1,847,903	€172.4k	0%	0.03%
1.94%	Alzecure Discovery AB	1,710,000	€159.5k	0%	no data
1.7%	Thomas Pollare	1,501,293	€140.1k	0%	no data
1.12%	Acturum Life AB	985,915	€92.0k	0%	no data
1.03%	Pontus Forsell	907,477	€84.7k	0%	no data
0.99%	Johan Sandin	875,834	€81.7k	0%	no data
0.46%	Martin Jönsson	409,466	€38.2k	0%	no data
0.14%	Birgitta Lundvik	122,500	€11.4k	0%	no data
0.084%	Marta Storck	74,166	€6.9k	0%	no data
0.056%	Ragnar Linder	49,698	€4.6k	0%	no data
0.028%	Janet Hoogstraate	25,000	€2.3k	0%	no data
0.0066%	FCG Fonder AB	5,797	€541.2	0%	no data
0.0028%	Eva Lilienberg	2,500	€233.1	0%	no data